Poly-ε-caprolactone composite scaffolds for bone repair

International Journal of Molecular Medicine

Volumn 34, Issue 6, 2014, Pages 1537-1546

  Di Liddo, R ^a   Paganin, P ^a   Lora, S ^b   Dalzoppo, D ^a   Giraudo, C ^a   Miotto, D ^a   Tasso, A ^a   Barbon, S ^b   Artico, M ^c   Bianchi, E ^c   Parnigotto, P P ^b   Conconi, M T ^a   Grandi, C ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Tissue Engineering and Signaling (TES) ONLUS   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bone extracellular matrix; Composite scaffolds; Mesenchymal stem cells; Osteogenic differentiation; Poly caprolactone

Indexed keywords

ALGINIC ACID; BIOMATERIAL; HYDROXYAPATITE; POLYCAPROLACTONE; BONE PROSTHESIS; GLUCURONIC ACID; HEXURONIC ACID; OSTEOCALCIN; OSTEOPONTIN; POLYESTER; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MATURATION; BONE PROSTHESIS; BONE REMODELING; CELL ADHESION; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; MESENCHYMAL STEM CELL; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; POROSITY; RABBIT; RAT; SCANNING ELECTRON MICROSCOPY; TRABECULAR BONE; ANIMAL; BONE; BONE MARROW CELL; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PHARMACOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; TISSUE SCAFFOLD; ULTRASTRUCTURE;

ALGINATES; ANIMALS; BONE AND BONES; BONE MARROW CELLS; BONE SUBSTITUTES; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DURAPATITE; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLUCURONIC ACID; HEXURONIC ACIDS; MESENCHYMAL STROMAL CELLS; MICROSCOPY, ELECTRON, SCANNING; OSTEOCALCIN; OSTEOGENESIS; OSTEOPONTIN; POLYESTERS; RABBITS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

EID: 84908072625     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1954     Document Type: Article

References (37)

1. Tabata Y: Biomaterial technology for tissue engineering applications. J R Soc Interface 6 (Suppl 3): 311-324, 2009.
2. Porter JR, Ruckh TT and Popat KC: Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnol Prog 25: 1539-1560, 2009.
3. Langer R and Vacanti JP: Tissue engineering. Science 260: 920-926, 1993.
4. Schmitz JP and Hollinger JO: A preliminary study of the osteogenic potential of a biodegradable alloplastic-osteoinductive alloimplant. Clin Orthop Relat Res 237: 245-255, 1988.
5. Mikos AG, Sarakinos G, Leite S.M., Vacanti JP and Langer R: Laminated threedimensional biodegradable foams for use in tissue engineering. Biomaterials 14: 323-330, 1993.
6. Agrawal CM and Kennedy MB: The effects of ultrasound irradiation on a biodegradable delivery system. Transactions of the Society for Biomaterials 19: 292, 1993.
7. Mooney DJ, Baldwin DF, Suh N P, Vacanti JP and Langer R: Novel approach to fabricate porous sponges of poly (D, L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials 17: 1417-1422, 1996.
8. Schugens C, Maquet V, Grandfils C., Jerome R and Teyssie P: Polylactide macroporous biodegradable implants for cell transplantation. II. Preparation of polylactide foams by liquid-liquid phase separation. J Biomed Mat Res 30: 449-461, 1996.
9. Grandi C, Di Liddo R, Paganin P, Lora S., Dalzoppo D, Feltrin G, Giraudo C., et al: Porous alginate/poly(ε-caprolactone) scaffolds: preparation, characterization and in vitro biological activity. Int J Mol Med 27: 455-467, 2011.
10. Costa-Pinto A.R., Reis RL and Neves NM: Scaffolds based bone tissue engineering: the role of chitosan. Tissue Eng Part B Rev 17: 331-347, 2011.
11. Karsenty G: The genetic transformation of bone biology. Genes Dev 13: 3037-3051, 1999.
12. Ito Y, Hasuda H, Kamitakahara M., Ohtsuki C, Tanihara M, Kang IK and Kwon OH: A composite of hydroxyapatite with electrospun biodegradable nanofibers as a tissue engineering material. J Biosci Bioeng 100: 43-49, 2005.
13. Thomas V, Jagani S, Johnson K., Jose M V, Dean DR, Vohra YK and Nyairo E: Electrospun bioactive nanocomposite scaffolds of polycaprolactone and nanohydroxyapatite for bone tissue engineering. J Nanosci Nanotechnol 6: 487-493, 2006.
14. Teng SH, Lee EJ, Wang P and Kim HE: Collagen/hydroxy-apatite composite nanofibers by electrospinning. Mater Lett 62: 3055-3058, 2008.
15. Ngiam M, Liao S, Patil A.J., Cheng Z., Chan CK and Ramakrishna S: The fabrication of nano-hydroxyapatite on PLGA and PLGA/collagen nanofibrous composite scaffolds and their effects in osteoblastic behavior for bone tissue engineering. Bone 45: 4-16, 2009.
16. Venugopal J, Low S, Choon A.T., Sampath Kumar TS and Ramakrishna S: Mineralization of osteoblasts with electrospun collagen/hydroxyapatite nanofibers. J Mater Sci Mater Med 19: 2039-2046, 2008.
17. Woodward SC, Brewer PS, Moatamed F, Schindler A and Pitt CG: The intracellular degradation of poly (epsilon-caprolactone). J Biomed Mater Res 19: 437-444, 1985.
18. Phipps MC, Clem WC, Catledge S.A., et al: Mesenchymal stem cell responses to bone-mimetic electrospun matrices composed of polycaprolactone, collagen I and nanoparticulate hydroxy-apatite. PLoS One 6: e16813, 2011.
19. Meezan E, Hjelle JT, Brendel K and Carlson EC: A simple, versatile, nondisruptive method for the isolation of morphologically and chemically pure basement membranes from several tissues. Life Sci 17: 1721-1732, 1975.
20. Albrektsson T and Johansson C: Osteoinduction, osteocon-duction andosseointegration. Eur Spine J 10 (Suppl 2): 96-101, 2001.
21. Hulbert SF, Young FA, Mathews R.S., Klawitter JJ, Talbert CD and Stelling FH: Potential of ceramic materials as permanently implantable skeletal prostheses. J Biomed Mater Res 4: 433-456, 1970.
22. Karageorgiou V and Kaplan D: Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26: 5474-5491, 2005.
23. Kaplan FS, Hayes WC, Keaveny T.M., Boskey A., Einhorn TA and Iannotti JP: Form and function of bone. In: Orthopaedic Basic Science. Simon SR (ed). American Academy of Orthopaedic Surgeons, Rosemont, IL, pp 127-185, 1994.
24. Cooper DM, Matyas JR, Katzenberg MA and Hallgrimsson B: Comparison of microcomputed tomographic and microradiographic measurements of cortical bone porosity. Calcif Tissue Int 74: 437-447, 2004.
25. Bauer TW and Muschler GF: Bone graft materials. An overview of the basic science. Clin Orthop Relat Res: 10-27, 2000.
26. Keating JF and McQueen MM: Substitutes for autologous bone graft in orthopaedic trauma. J Bone Joint Surg 83: 3-8, 2001.
27. Damien E, Hing K, Saeed S and Revell PA: A preliminary study on the enhancement of the osteointegration of a novel synthetic hydroxyapatite scaffold in vivo. J Biomed Mater Res A 66: 241-246, 2003.
28. Kim HD and Valentini RF: Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro. J Biomed Mater Res 59: 573-584, 2002.
29. Bignon A, Chouteau J, Chevalier J., Fantozzi G, Carret J P, Chavassieux P, Boivin G., Melin M and Hartmann D: Effect of micro- and macroporosity of bone substitutes on their mechanical properties and cellular response. J Mater Sci Mater Med 14: 1089-1097, 2003.
30. Ahuja G and Pathak K: Porous carriers for controlled/modulated drug delivery. Indian J Pharm Sci 71: 599-607, 2009.
31. Kuboki Y, Takita H, Kobayashi D., et al: BMP-induced osteo-genesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: topology of osteogenesis. J Biomed Mater Res 39: 190-199, 1998.
32. Tsuruga E, Takita H, Itoh H., Wakisaka Y and Kuboki Y: Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. J Biochem 1: 317-324, 1997.
33. Gotz HE, Muller M, Emmel A., Holzwarth U, Erben RG and Stangl R: Effect of surface finish on the osseointegration of laser-treated titanium alloy implants. Biomaterials 25: 4057-4064, 2004.
34. Yuan H, Kurashina K, de Bruijn JD, Li Y, de Groot K and Zhang X: A preliminary study on osteoinduction of two kinds of calcium phosphate ceramics. Biomaterials 20: 1799-1806, 1999.
35. Dong SW, Ying DJ, Duan X.J., et al: Bone regeneration using an acellular extracellular matrix and bone marrow mesenchymal stem cells expressing Cbfa1. Biosci Biotechnol Biochem 73: 2226-2233, 2009.
36. Komori T, Yagi H, Nomura S., et al: Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to matura-tional arrest of osteoblasts. Cell 89: 755-764, 1997.
37. Inada M, Yasui T, Nomura S., et al: Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 214: 279-290, 1999.